Brookfield Asset Management Inc. Y M Abs Therapeutics, Inc. Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	BUY	$27.47 - $37.31 $345,627 - $469,434	12,582 Added 7.55%	179,236 $5.12 Million
Q2 2021 Aug 17, 2021	BUY	$25.45 - $37.64 $1.5 Million - $2.22 Million	58,954 Added 54.74%	166,654 $5.63 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $1.86 Million - $3.31 Million	63,700 Added 144.77%	107,700 $3.26 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $1.67 Million - $2.39 Million	44,000 New	44,000 $2.18 Million

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.